New wound matrix shows promise for diabetic foot ulcers

NCT ID NCT03312595

Completed Disease control Sponsor: Acera Surgical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a special wound dressing called Restrata Wound Matrix on 30 adults with diabetic foot ulcers. The goal was to see how well it helped wounds close and whether it was safe. Results may guide future research on this treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Restrata Wound Matrix (a skin substitute device)
What this could lead to: If successful, this could support using Restrata to help heal diabetic foot ulcers more effectively.
What could go wrong: This is a small, early case series with only 30 people and no comparison group. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT ULCER

Contacts and locations

Locations

Advanced Foot Care And Clinical Research Center

Fresno, California, 93722, United States
Arizona Reginal Medical Research

Tucson, Arizona, 85710, United States
Associated Foot & Ankle Specialists

Phoenix, Arizona, 85015, United States
Richard C. Galperin, DPM

Dallas, Texas, 75208, United States
SAVAHCS

Tucson, Arizona, 85723, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.